ASSOCIATION BETWEEN SMOKING BEHAVIOUR AND GLYCOHEMOGLOBINE LEVELS AMONG ADULT JAVANESE INDONESIAN SMOKERS

Christine Patramurti(1*), Fenty Fenty(2),

(1) Faculty of Pharmacy, Sanata Dharma University, Yogyakarta
(2) Faculty of Pharmacy, Sanata Dharma University, Yogyakarta
(*) Corresponding Author

Abstract


Nicotine, the active compound in cigarettes, can cause impaired glucose metabolism by
increasing insulin resistance as well as decreasing insulin secretion in ? cell pancreas. This
condition can increase the risk of type 2 diabetes in human. This study aims to evaluate the effect
of smoking behaviour, determined by Cigarette per Day (CPD) and smoking duration, on
glychohemoglobine (HbA1c) levels of Javanese Indonesian smokers. 30 smokers were studied
consisting of 7 smokers with <10 CPD, 19 smokers with 11-20 CPD and 4 smokers with 21-30
CPD. They had been smoking for more than 10 years. The whole blood sample was used to
examine the HbA1c levels. The HbA1c levels were tested at Bethesda Hospital's clinic
laboratories using Architect 600 instrument. The results showed that CPD and smoking duration
significantly influenced HbA1c, in which F count was > F table (370.541> 3.354) with
significance < 0.05 (2.35. 10-20 < 0.05) and multiple correlation coefficient (R) of 0.982.
Therefore, based on this research finding, it was concluded that longer smoking duration and
higher CPD caused higher smokers HbA1c level.


Keywords


CPD; HbA1c; smoking behaviour; smoking duration.

Full Text:

PDF

References


ADA. 2011. Standards of Medical Care in Diabetes. Diabetes Care, 34, S11S61.

ADA. 2014. Standards of Medical Care in Diabetes. Diabetes Care, 37, S14S80.

Ando, M., Hamajima, N., Ariyoshi, N., Kamataki, T., Matsuo, K., Ohno, Y. 2003. Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults. Journal of Epidemiology, 13(3), 176181.

Ariyoshi, N., Miyamoto, M., Umetsu, Y. 2002. Genetic Polymorphism of CYP2A6 Gene and Tobacco-induced Lung Cancer Risk in Male Smokers Genetic Polymorphism of CYP2A6 Gene and Tobacco-induced Lung Cancer Risk in Male Smokers. Cancer Epidemiol Biomarkers Prev, 11, 890894.

Bajaj, M. 2012. Nicotine and Insulin Resistance: When the Smoke Clears. Diabetes, 16, 30783080.

Bergman, B. C., Perreault, L., Hunerdosse, D., Kerege, A., Playdon, M., Samek, A. M., Eckel, R. H. 2012. Novel and Reversible Mechanisms of Smoking-Induced Insulin Resistance in Humans. Diabetes, 111.

Borowitz, J.L., Isom, G.E. 2008. Toxicological Highlight Nicotine and Type 2 Diabetes. Toxicol. Sci., 103(2), 225227.

Chang, S.A. 2012. Smoking and Type 2 Diabetes Mellitus. Diabetes Metabolism Journal, 36(6), 399403.

Chenoweth, M.J., OLoughlin, J., Sylvestre, M.-P., Tyndale, R. F. 2013. CYP2A6 Slow Nicotine Metabolism is Associated with Increased Quitting by Adolescent Smokers. Pharmacogenet. Genomics., 23(4), 2325.

Cho, N. H., Chan, J.C.N., Jang, H.C., Lim, S., Kim, H.L., Choi, S.H. 2009. Cigarette Smoking is An Independent Risk Factor for Type 2 Diabetes?: a Four-Year Community-Based Prospective Study. J. Clin. Endocrinol., 71, 679685.

Foy, C.G., Bell, R.A., Farmer, D.F., Goff, D. C., Wagenknecht, L.E. 2005. Smoking and Incidence of Diabetes Among U.S. Adults Findings from the Insulin Resistance Atherosclerosis Study. Diabetes Care, 28(10), 25012507.

Fujieda, M., Yamazaki, H., Saito, T., Kiyotani, K., Gyamfi, M.A., Sakurai, M., Akita-Dosaka, H., Sawamura, Y., Yokota, J., Kunitoh, H., Kamataki, T. 2004. Evaluation of CYP2A6 Genetic Polymorphisms as Determinants of Smoking Behavior and Tobacco-Related Lung Cancer Risk in Male Japanese Smokers. Carcinogenesis, 25(12), 24512458.

Hang, L.U.Z. 2011. Association Between Passive and Active Smoking and Incident Type 2 Diabetes in Women. Diabetes Care, 34, 892897.

Harris, K. K., Zopey, M., Friedman, T.C. 2016. Metabolic Effects of Smoking Cessation. Nature Reviews. Endocrinology, 12, 299308.

Houston, T. K., Person, S.D., Pletcher, M. J., Liu, K., Iribarren, C., Kiefe, C. I. 2006. Active and Passive Smoking and Development of Glucose Intolerance among Young Adults in a Prospective Cohort: CARDIA Study. BMJ, 332(7549), 10641069.

IDF. 2015. IDF Diabetes Atlas (Seventh Ed). Karakas: Karakas Print. www.diabetesatlas.org. (accessed 12.10.19).

Jee, S. H., Foong, A.W., Hur, N. W., Samet, J. M. 2010. Smoking and Risk for Diabetes Incidence and Mortality in Korean Men and Women. Diabetes Care, 33(12), 25672572.

Jyothirmayi, B., Kaviarasi, S., William, E. 2013. Study of Glycated Hemoglobin in Chronic Cigarette Smokers. Medical Science, 5(1), 46.

Kawakami, N., Takatsuka, N., Shimizu, H., Ishibashi, H. 1997. Effects of Smoking on the Incidence of Non-lnsulin-dependent Diabetes Mellitus. American Journal of Epidemiology, 145(2), 103109.

Kowall, B., Rathmann, W., Strassburger, K., Heier, M., Holle, R., Thorand, B., Giani, G., Peters, A., Meisinger, C. 2010. Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population?: the KORA S4 / F4 cohort study. Eur J Epidemiol. 25(6), 393-402.

Lian, T.Y., Dorotheo, U. 2014. The ASEAN Tobacco Control Atlas Second Edition. Bangkok: SEATCA. www.seatca.org (accessed 12.10.19).

Liu, T., Chen, W.-Q., David, S. P., Tyndale, R. F., Wang, H., Chen, Y.-M., Yu, Q.-X., Chen, W., Zhou, Q., Ling, W.-H. 2011. Interaction Between Heavy Smoking and CYP2A6 Genotypes on Type 2 Diabetes and Its Possible Pathways. European Journal of Endocrinology, 165, 961967.

Loria, P., Lonardo, A., Anania, F. 2013. Liver and Diabetes. A Vicious Circle. Hepatol Res., 43(1), 5164.

Luo, J., Rossouw, J., Tong, E., Giovino, G. A., Lee, C. C., Chen, C., Ockene, J.K., Qi, L., Margolis, K. L. 2013. Smoking and Diabetes?: Does the Increased Risk Ever Go Away?? American Journal of Epidemiology, 178(6), 937945.

Minematsu, N., Nakamura, H., Furuuchi, M., Nakajima, T., Takahashi, S., Tateno, H., Ishizaka, A. 2006. Limitation of Cigarette Consumption by CYP2A6*4, *7 and *9 polymorphisms. The European Respiratory Journal, 27, 289292.

Nakanishi, N., Nakamura, K., Matsuo, Y., Suzuki, K., Tatara, K. 2000. Cigarette Smoking and Risk for Impaired Fasting Glucose and Type 2 Diabetes in Middle-Aged Japanese Men. Annals of Internal Medicine, 133, 183191.

Nilsson, P. M., Ardanaz, E., Gavrila, D., Agudo, A. 2014. Smoking and Long-Term Risk of Type 2 Diabetes?: The EPIC- InterAct Study in European Populations. Diabetes Care, 37, 31643171.

Nilsson, P.M., Gudbjrnsdottir, S., Eliasson, B., Cederholm, J. 2004. Smoking is Associated with Increased HbA1c Values and Microalbuminuria in Patients with Diabetes Data from The National Diabetes Register in Sweden. Diabetes Metabolism, 30, 261268.

OLoughlin, J. 2004. Genetically Decreased CYP2A6 and The Risk of Tobacco Dependence: A Prospective Study of Novice Smokers. Tobacco Control, 13, 422428.

Padhy, S., Dash, H.S. 2015. Study of Lipid Profile and Glycosylated Hemoglobin in Smokers. Medical Science, 5(6), 519520.

Padmawati, R.S., Ng, N., Prabandari, Y. S., Nichter, M. 2009. Smoking among Diabetes Patients in Yogyakarta, Indonesia?: Cessation Efforts are Urgently Needed. Trop. Med. Int. Health, 14(4), 412419.

Patramurti, C., Fenty, 2019. Genetic Polymorphism of Cytochrome P450 2A6 Allele * 4 and * 9?: Study on Glycohemoglobine Level Among Javanese Indonesian Smokers. PSR, 6(2), 8288.

RI, K.K. 2009. Tahun 2030 Prevalensi Diabetes Melitus di Indonesia Mencapai 21,3 Juta Orang. www.depkes.go.id (accessed 8.8.19).

Rao, Y., Hoffmann, E. W. A., Zia, M., Bodin, L., Zeman, M., Sellers, E. M., Tyndale, R. F. 2000. Duplications and Defects in the CYP2A6 Gene?: Identification, Genotyping, and In Vivo Effects on Smoking. Mol. Pharmacol, 58(4), 747755.

Reinhard H.A., Becker, S.S., Annke D. Frick, R.J.F. 2006. The Effect of Smoking Cessation and Subsequent Resumption on Absorption of Inhaled Insulin. Diabetes Care, 29(2), 277282.

Saeed, A.A. 2012. Association of Tobacco Products Use and Diabetes Mellitus-Results of a National Survey Among Adults in Saudi Arabia. Balkan Med J, 29, 247251.

Schoedel, K.A, Hoffmann, E.B., Rao, Y., Sellers, E.M., Tyndale, R.F. 2004. Ethnic Variation in CYP2A6 and Association of Genetically Slow Nicotine Metabolism and Ssmoking in Adult Caucasians. Pharmacogenetics, 14, 615626.

Stadler, M., Tomann, L., Storka, A., Wolzt, M., Peric, S., Bieglmayer, C., Pacini, G., Dickson, S.L., Brath, H., Bech, P., Prager, R., Korbonits, M. 2014. Effects of Smoking Cessation on b-cell Function, Insulin Sensitivity, Body Weight, and Appetite. Eur J of Endocrinology, 170, 219227.

Sun, K., Liu, J., Ning, G. 2012. Active Smoking and Risk of Metabolic Syndrome?: A Meta-Analysis of Prospective Studies. Plos One, 7(10), e47791.

Tandilittin, H., Luetge, C. 2013. Civil Society and Tobacco Control in Indonesia: The Last Resort. Open Ethics Journal, 7(1), 1118.




DOI: https://doi.org/10.24071/jpsc.002408

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Jurnal Farmasi Sains dan Komunitas (Journal of Pharmaceutical Sciences and Community)

 

 

 

 

 

 

 

  

Jurnal Farmasi Sains dan Komunitas (Journal of Pharmaceutical Sciences and Community)

Published by Faculty of Pharmacy, Universitas Sanata Dharma Yogyakarta

Creative Commons Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.